Voorbeelden van het gebruik van Both trials in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
Both trials achieved the primary endpoints(ACR20).
The treatment effect was consistent in both trials.
Unfortunately, both trials failed to improve HD symptoms.
Source Document Verification of two randomly selected, patients; of both trials one patient.
Both trials were viewed by domestic
statistically significant improvement in PFS was observed in both trials.
In both trials, Extavia showed a reduction in the number(30%)
be informed about the course of both trials.
In both trials, treatment with Thelin resulted in a significant increase in exercise capacity.
It is used in both trials to source of plant material for improvement,
In both trials, treatment with lumacaftor/ivacaftor resulted in a statistically significant improvement in ppFEV1 Table 3.
The overall change in WHO functional class during both trials was significantly better among Tracleer-treated patients as compared with placebo-treated patients.
Both trials demonstrated significant improvement in PFS of EGFR mutation positive patients treated with GIOTRIF compared to chemotherapy.
Combined analysis of both trials showed that 83% of patients who received Faslodex progressed, compared with 85% of patients who received anastrozole.
In both trials, the primary endpoint was progression-free survival(PFS)
A trend was observed in both trials in the improvement of MBS from baseline to week 4 in favour of ospemifene compared to placebo,
In both trials secondary progressive multiple sclerosis patients receiving Extavia showed a reduction in frequency(30%)
The primary endpoint in both trials was the proportion of responder patients that achieved plasma uric acid(PUA)
In both trials there was a reduction(30%) in frequency of
Patients in both trials were randomised 1:1:1 to receive lumacaftor 600 mg once daily/ivacaftor 250 mg q12h,
In both trials, most cases of hypertension in patients treated with Stivarga appeared during the first cycle of treatment
In both trials, most cases of hand-foot skin reaction in patients treated with Stivarga appeared during the first cycle of treatment
Both trials showed a statistically significant superiority to placebo in reducing the rate of acute renal allograft rejection at six months post-transplant as confirmed by biopsy.
Results from both trials indicated that continued ranibizumab treatment may also be of benefit in patients who lost≥15 letters of best-corrected visual acuity(BCVA)
For inclusion in both trials, treatment-naive patients had to have genotypic sensitivity to REYATAZ